Indications

Resvera-Pro™ is an antioxidant formula for the maintenance of good health. It helps to support eye health, cardiovascular health and relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as the sensation of swelling, heaviness and tingling of the legs.

Ingredients

Each capsule contains

Resveratrol (pure polygonum) … 100mg
Grape seed extract (vitis vinifera, 95% proanthocyanidins) … 150mg
Coenzyme Q10 (ubidecaranone) … 30mg
Black Currant extract (ribes nigrum, 110:1, 36% anthocyanosides) … 50mg
Bilberry extract (vaccinium myrtillus, 4:1) … 50mg
Quercetin (dihydrate) … 180mg

Non-medicinal ingredients: Vegetable-grade magnesium stearate, vegetable capsule.

Description

Experts have long supported the fact that drinking a glass of red wine a day can be good for your health. The credit for this health benefit might be attributed to a polyphenol called resveratrol found in the skin of red grapes, in grape seeds and black currants.

Polyphenols, or plant chemical compounds, are antioxidants that prevent cells in your body from breaking down, or “oxidizing”. Free radicals produced in the body help us with digestion and the conversion of food into energy. But they can easily turn from beneficial to harmful when their numbers get out of hand, damaging cell structures in their wake (oxidation) and leaving us prone to disease. The antioxidant properties of resveratrol work to especially protect our cardiovascular health and help combat aging.

Resveratrol may also help guard against hypertension by decreasing inflammatory cells in blood vessel walls and by improving the vessel’s ability to respond to changes in blood pressure. Resveratrol also contributes to reducing the stickiness of platelets in our blood, which makes them less likely to form clots and potentially lead to a heart attack or stroke.

Resvera-Pro™ is a powerful formulation that captures the mighty health benefits of grape seeds, red wine, quercetin, coenzyme Q10 and black currants in a single, concentrated formula with an exceptionally high ORAC (oxygen radical absorption capacity) value. Resvera-Pro™ helps to support cardiovascular health and relieve symptoms associated with non-complicated chronic venous insufficiency (CVI). Cheers to your good health !

Quantity

60 vegetable capsules

Dose

Adults - Take 1 capsule 1 to 2 times per day or as directed by a healthcare practitioner. Consult a healthcare practitioner for use beyond four weeks.

Potential side effects/Safety

Cautions and Warnings:
Contraindicated in pregnant and breastfeeding women.

Caution advised with medical conditions including liver disorders.

Drug interactions:
Caution advised when used concurrently with any natural health product or prescription medication including blood pressure medication.

Side effects:
User should discontinue use if diarrhoea occurs.

References

"Show references"

"Hide references"

Bagchi D, Das DK, Tosaki A, Bagchi M, Kothari SC (2001). Benefits of Resveratrol in Women's Health. Drugs Under Experimental and Clinical Research. Vol 27, no 506. pp 233-248.

Boots AW, Haenen GR and Bast A. “Health Effects of Quercetin: From Antioxidant to Nutraceutical.” European Journal of Pharmacology 585 (2008): 325-37.

Head, Kathleen A. Natural Therapies for Ocular Disorders, Part One: Diseases of the Retina Altern Med Rev 1999;4(5):342-359.

The Linus Pauling Institute: www. lpi.oregonstate.edu/infocenter/phytochemicals/resveratrol/index.

Lyall Kathleen, Hurst SM, Cooney J, Jensen D, Lo K, Hurst RD and Stevenson LM (2009). Short-term blackcurrant extract consumption modulates exercise-induced oxidative stress and lipopolysaccharide-stimulated inflammatory responses. Am J Physiol Regul Integr Comp Physiol 297: R70-R81.

Murray, Michael (1996). Encyclopedia of Nutritional Supplements. Prima Health, USA.

Nakaishi H, Matsumot H, Tominaga S and Hirayama M (2000). Effects of black currant anthocyanoside intake on dark adaptation and VDT work-induced transient refractive alteration in healthy humans. Alternative Medicine Review. Vol 5, Number 6 pp 553-562.